Experts predict myopia, or nearsightedness, will reach epidemic proportions by the end of the decade, with over a third of the world’s population requiring glasses or contact lenses. However, if a team of Israeli ophthalmologists from Jerusalem’s Shaare Zedek Medical Center has their way, the crisis may be averted with special “nanodrops” created to correct refractive errors responsible for nearsightedness (myopia), farsightedness (hyperopia), or blurred vision (astigmatism).